Vasopressor agents are prescribed when hypotension persists despite fluid administration or in cases of severe hypotension during ongoing fluid resuscitation. It is essential to recognize that the criteria for initiating vasopressors are subjective and lack precise definitions. Therefore, clinicians must conduct a patient-specific evaluation to determine what constitutes severe hypotension or hypotension refractory to fluid therapy in each individual case. This personalized assessment ensures that treatment decisions are tailored to the patient’s unique clinical presentation and needs. The choice of a particular vasopressor agent is primarily influenced by expert opinion and individual clinician preference.